Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Objective Recent studies have provided variable information on the frequency and context of diversion and the use of nonprescribed and prescribed stimulant medications in adolescent and young adult populations. The purpose of this systematic review of the literature is to evaluate the extent and characteristics of stimulant misuse and diversion in attention-deficit/hyperactivity disorder (ADHD) and non-ADHD individuals. Method We conducted a systematic review of the literature of available studies looking at misuse and diversion of prescription ADHD medications using misuse, diversion, stimulants, illicit use, and ADHD medications as key words for the search. Results We identified 21 studies representing 113,104 subjects. The studies reported rates of past year nonprescribed stimulant use to range from 5% to 9% in grade school- and high school-age children and 5% to 35% in college-age individuals. Lifetime rates of diversion ranged from 16% to 29% of students with stimulant prescriptions asked to give, sell, or trade their medications. Recent work suggests that whites, members of fraternities and sororities, individuals with lower grade point averages, use of immediate-release compared to extended-release preparations, and individuals who report ADHD symptoms are at highest risk for misusing and diverting stimulants. Reported reasons for use, misuse, and diversion of stimulants include to concentrate, improve alertness, "get high," or to experiment. Conclusions The literature…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and there have been reports of abuse and misuse of stimulant ADHD medication (Kollins, MacDonald, & Rush, 2001; Wilens et al., 2008).”
From Stimulant ADHD medication and risk for substance abuse (2014) · cites this paper as Wilens et al., 2008
In the citing paper
“substantial data indicate that a minority of patients with ADHD divert their stimulant medication for misuse byothers 176 .”
From Attention-deficit/hyperactivity disorder (2015) · cites this paper as [176]
In the citing paper
“Given the burden of attention, behavioural and cognitive deficits often noted in children with ADHD and concerns about over prescription of medications with side effects [116], exercise could hold promise as an adjunctive treatment and requires testing in robust well-powered RCTs.”
From Exercise as Medicine for Mental and Substance Use Disorders: A Meta-review of the Benefits for Neuropsychiatric and Cognitive Outcomes (2020) · cites this paper as [116]
In the citing paper
“Long-acting preparations improve compliance and may decrease the potential for abuse, misuse, or recreational use.”
From Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder (2017) · cites this paper as [8]
In the citing paper
“the long-acting formulations are associated with a lower abuse potential compared with the shorter acting formulations”
From Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder (2017) · cites this paper as [8]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
Self-citation(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
The Worldwide prevalence of ADHD: is it an American condition?
Faraone, S. V., Sergeant, J. A., Gillberg, C., & Biederman, J. (2003) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) · Cited by 1,516
Mannuzza, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820190067007 · Cited by 1,368
General hospital psychiatry: the Italian experience.
Faraone, S. V., Sergeant, J. A., Gillberg, C., & Biederman, J. (2003) · Europe PMC (PubMed Central) · Cited by 1,317
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1325 · Cited by 885
Cited by
Items 501–600 of 823
The Role of Counterfactual Thinking on Attitudes Toward ADHD Medication Use
Ramos, A. M., Becker, B., Biemer, J. A., Clark, L., Fields, S. A., & Smallman, R. (2016) · Substance Use & Misuse · doi:10.3109/10826084.2015.1126739 · Cited by 5
Managing ADHD in Adults with Common Comorbidities
Sobanski, E., Paslakis, G., Schredl, M., Daffner, S., & Alm, B. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-248-3_8 · Cited by 7
Pliszka, S. R. (2012) · Wiley eBooks · doi:10.1002/9781119958338.ch6 · Cited by 5
Kitaneh, R., Khave, L. J., Ysrayl, B. B., Borelli, A., Funaro, M. C., Potenza, M. N., & Angarita, G. A. (2024) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-024-00278-7 · Cited by 4
“Therefore, there is considerable interest in interventions that boost treatment effectiveness while minimizing adverse effects [31, 32].”
Do Stimulant Medications for Attention-Deficit/Hyperactivity Disorder (ADHD) Enhance Cognition?
Advokat, C. D., & Vinci, C. (2012) · InTech eBooks · doi:10.5772/29889 · Cited by 8
“The increase in stimulant prescriptions has resulted in a corresponding escalation of illicit use, particularly in college students, confirmed by numerous survey results (Advokat et al., 2008; Arria & DuPont, 2010; Hall et al., 2005; McCabe et al., 2005; Rabiner et al., 2008; 2009a, 2009b; Rabiner et al., 2010; Teter…”
Improving the Treatment Outcomes for ADHD Patients with IS/IT: An Actor-Network Theory Perspective
Binhadyan, B., Troshani, I., & Wickramasinghe, N. S. (2014) · International Journal of Actor-Network Theory and Technological Innovation · doi:10.4018/ijantti.2014100104 · Cited by 4
The Modulation of Hippocampus Plasticity
Popa, L. L., Chira, D., Asaftei, A., Strilciuc, Ș., & Muresanu, D. F. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110386 · Cited by 7
Uses of psychotropic drugs by university students in Switzerland
Berchtold, A., Genre, N., & Panese, F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0305392 · Cited by 7
Weyandt, L. L., & DuPaul, G. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5345-1_4 · Cited by 5
Bodey, C. (2011) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s6615 · Cited by 6
Cognitive enhancement: a brief overview
Outhoff, K. (2016) · South African Family Practice · doi:10.4102/safp.v58i1.4436 · Cited by 4
Leaving the nest: anticipatory guidance for the college-bound youth
Sidhu, S. K., & ADESMAN, A. R. (2017) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000550 · Cited by 7
Les médicaments détournés de leur usage médical par les jeunes : une revue de la littérature
Milhet, M. (2018) · Psychotropes · doi:10.3917/psyt.233.0105 · Cited by 4
Le TDAH chez les enfants et les adolescents, partie 2 : le traitement
Feldman, M. E., Charach, A., & Bélanger, S. A. (2018) · Paediatrics & Child Health · doi:10.1093/pch/pxy114 · Cited by 11
Prescription Medication Misuse
Hill, J., & Alford, D. P. (2018) · Seminars in Neurology · doi:10.1055/s-0038-1673691 · Cited by 4
Pharmakologisches Neuroenhancement
Maier, L. J. (2015) · Springer eBooks · doi:10.1007/978-3-642-55214-4_60-1 · Cited by 4
Preventing the Next Epidemic: Prescribed Stimulant Abuse
Via, K. D. (2019) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2018.12.012 · Cited by 5
Sattler, S., & Wörn, J. (2019) · Advances in neuroethics · doi:10.1007/978-3-030-10677-5_7 · Cited by 4
Hurst, J. N., Eassey, J. M., Baldwin, J. M., & ten Bensel, T. (2020) · Journal of Drug Issues · doi:10.1177/0022042620961358 · Cited by 6
“…seniors nationwide (e.g., Johnston et al., 2016; McCabe et al., 2018; Substance Abuse and Mental Health Services Administration [SAMHSA], 2019; Wilens et al., 2008).1,2 Contributing to these trends is the observation that prescription stimulants are readily available for nonmedical use on…”
BackgroundThe Medical Ethics of Cognitive Neuroenhancement
Cheung, E. H., & Pierre, J. M. (2015) · AIMS neuroscience · doi:10.3934/neuroscience.2015.03.105 · Cited by 5
ADHD psychopharmacology across the lifespan
Vitiello, B. (2009) · Current Attention Disorders Reports · doi:10.1007/s12618-009-0010-7 · Cited by 4
““Diversion” refers to the transfer of the medication from the patient to whom it was prescribed to someone else [ 39 ].”
BackgroundPeña, I. D., Ahn, H. S., Shin, C., & Cheong, J.-H. (2011) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2011.19.1.009 · Cited by 6
“However, a recent clinical survey has reported that stimulant ADHD medications are being abused, not only by “healthy” individuals, but also by ADHD patients themselves (Wilens et al., 2008).”
BackgroundInfluentialDexmethylphenidate for attention deficit hyperactivity disorder
Coury, D. L. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903386284 · Cited by 4
Ritalin Dose Response Effect on Medial Prefrontal Cortex and on Animal Behavior
Reyes-Vasquez, C., Cannon, C. J., & Dafny, N. (2016) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2016.63015 · Cited by 4
“Methylphenidate (MPD), a psychostimulant synthesized over fifty years ago, has become the drug of choice for treating ADHD in more than 90% of patients in the United States [2] [12].”
InfluentialFranke, A. G., Lehmberg, S., & Soyka, M. (2016) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-016-0077-y · Cited by 8
“students in a systematic review [2]; however, PN was only one of the reasons listed for stimulant use.”
BackgroundNeurodevelopmental Disorders: Attention‐Deficit/Hyperactivity Disorder
Newcorn, J. H., Leikauf, J. E., Johnson, B., Krone, B., & Halperin, J. M. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch45 · Cited by 5
Alobaid, R. A., Alazzaz, A. A., Alzahrani, Z. A., Alqusiyer, A. A., Badghaish, A. K., Alsaqabi, M. K., Aldeligan, S. H., Abdulghani, H. M., & Ahmad, T. (2025) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_2080_24 · Cited by 4
Goodman, D. W., Mago, R., Citrome, L., Swartz, H. A., McIntyre, R. S., Freeman, M. P., Clayton, A. H., Kasper, S. F., Vieta, E., Williams, A. R., et al. (2026) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2026.112863 · Cited by 4
Improving the Treatment Outcomes for ADHD Patients with IS/IT: An Actor-Network Theory Perspective
Binhadyan, B., Troshani, I., & Wickramasinghe, N. S. (2015) · IGI Global eBooks · doi:10.4018/978-1-4666-8756-1.ch064 · Cited by 3
Subtypes of prescription stimulant misuse among students: a nuanced story
Bruyn, S. D., Wouters, E., Ponnet, K. S., Tholen, R., & Hal, G. F. V. (2023) · Studies in Higher Education · doi:10.1080/03075079.2023.2215272 · Cited by 5
“Firstly, previous research speci fi ed that having ADHD symptoms is linked to stimulant misuse (Benson et al. 2018; Wilens et al. 2008).”
BackgroundHow can (or could) biology inform more effective parenting interventions for childhood aggression?
Perkins, E. R., Mossin, I., Goldstein, N. E. S., Jaffee, S. R., NeMoyer, A., Hernandez‐Pena, L., Wallace, A. A., Saven, H. Q., Perlstein, S., Gardner, F. E. M., et al. (2024) · Aggression and Violent Behavior · doi:10.1016/j.avb.2024.101985 · Cited by 3
Żełabowski, K., Petrov, W., Ślebioda, D., Rusinek, M., Biedka, K., Błaszczyk, K., Wesołowski, M., Wojtysiak, K., Sroka, M., Ratka, Z., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14186470 · Cited by 4
“Furthermore, patients with ADHD comorbid behavioral disorders like anxiety or mood instability accounted for the bulk of smokers [53].”
Dockery, C. A. (2013) · Trends in augmentation of human performance · doi:10.1007/978-94-007-6253-4_8 · Cited by 3
Attention Deficit Hyperactivity Disorder Treatment Practice in Turkey
Öner, Ö., Türkçapar, M. H., İşli, F., Karadağ, H., Akbulat, A., Basci, A. B., Aksoy, M., Seckin, C., & Alkan, A. (2016) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20151202103706 · Cited by 6
“When 6-18 years group was divided into three (6-10, 11-14, 15-18), it was evident that rate of IR MPH prescriptions was highest at 6-10 years group, and atomoxetine prescriptions rate was lowest at 15-18 years group.”
BackgroundMannem, N., Mehta, T., Nagarajan, E., Yarasi, N., & Bollu, P. C. (2021) · Current Developmental Disorders Reports · doi:10.1007/s40474-020-00215-9 · Cited by 5
Mendez, J., Yomogida, K., Figueroa, W., Roldan, K. D., & Bavarian, N. (2021) · Journal of Ethnicity in Substance Abuse · doi:10.1080/15332640.2021.1952128 · Cited by 5
“This finding contradicts prior literature that has identified students who are White as more likely to engage in more frequent misuse (Wilens et al., 2008).”
BackgroundResultAlvarenga, J. V., Fernandes, B. L. A., Maia, T. L., Guimarães, L. C., Cruvinel, A. R., Vieira, B. C., Alves, L. P., & Azevedo, G. F. C. (2023) · Revista Foco · doi:10.54751/revistafoco.v16n9-099 · Cited by 3
Bright, U., Overstreet, C. M., Levey, D. F., & Gelernter, J. E. (2025) · Psychological Medicine · doi:10.1017/s0033291725101293 · Cited by 5
“…et al., 2018; López & Becoña, 2007; Rogers et al., 2021), or if they are commonly associated with the use of, or treatment via, specific substances (e.g. ADHD, which is associated with stimulant use [Wilens et al., 2008], and chronic pain, which is associated with opioid use [Weiss et al., 2014]).”
da Cunha, R. A. B., & Relvas, J. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804205-2.00003-3 · Cited by 5
Social Media Ethics Section 2: Ethical Research with Social Media
Parsons, T. D. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108553384.011 · Cited by 3
Drug and alcohol addiction: new pharmacotherapies
Luty, J. S. (2015) · BJPsych Advances · doi:10.1192/apt.bp.114.013367 · Cited by 4
“Wilens et al (2008) reviewed 21 studies (involving over 100 000 children and adolescents) assessing the diversion and misuse of stimulants (primarily methylphenidate) prescribed for ADHD.”
Assessment and Treatment of ADHD in Adults
Weiss, N. (2011) · Psychiatric Annals · doi:10.3928/00485713-20101221-05 · Cited by 4
Hirndoping: Die Position der Deutschen Hauptstelle für Suchtfragen e.V. (DHS)
Glaeske, G., Merchlewicz, M., Schepker, R., Soellner, R., Böning, J., & Gaßmann, R. (2011) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/0939-5911.a000141 · Cited by 5
Aghili, H. A., Yassaei, S., Zahir, S. T., & Arjmandi, R. (2017) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2017/26217.10169 · Cited by 5
Drugs to Treat Attention Deficit Hyperactivity Disorder (ADHD)
Müller, U., & Sedgwick-Müller, J. A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623465.015 · Cited by 4
Stimulants: Definition, Pharmacology, Indications, Side Effects, and Treatment Strategies
Steinbuchel, P. H., & Greenhill, L. L. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_324-1 · Cited by 6
Owens, J. S., Hustus, C. L., Everly, E. L., Evans, S. W., & Margherio, S. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818697-8.00029-7 · Cited by 3
An, Y., Song, Y., & Kang, U. G. (2022) · 신경정신의학 · doi:10.4306/jknpa.2022.61.2.45 · Cited by 3
Pharmacotherapy of ADHD in Adults
Rösler, M., Retz, W., & Turner, D. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_254 · Cited by 4
Amphetamine and Methamphetamine
Barceloux, D. G. (2012) · Wiley eBooks · doi:10.1002/9781118105955.ch1 · Cited by 3
Fossos‐Wong, N., Litt, D., King, K. M., Kilmer, J. R., Fairlie, A. M., Larimer, M. E., Lee, C. M., Geisner, I. M., Cimini, M. D., & Lewis, M. A. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.2003403 · Cited by 2
“…for these relatively high rates of misuse among young adults is that young adults generally assume greater responsibility for their own medication management, which in turn may lead to greater availability of prescription drugs (McCabe & Boyd, 2005; Wilens et al., 2008), compared to adolescents.”
BackgroundPerceptions of stimulant and buprenorphine diversion and strategies to address it
Uscher‐Pines, L., Sousa, J., Raja, P. V., Mehrotra, A., Busch, A. B., & Huskamp, H. A. (2024) · Health Affairs Scholar · doi:10.1093/haschl/qxae074 · Cited by 2
Steiner, H., Hrabak, M., & Bolaños‐Guzmán, C. A. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106344 · Cited by 2
Hussain, T., Neupane, P., & Khunger, V. (2025) · Cureus · doi:10.7759/cureus.92423 · Cited by 4
“Studies show that the lifetime risk of stimulant diversion amongst ADHD individuals is as high as 24-26% of patients selling, trading or sharing their medications, although there is variation between studies [73-75].”
Hernández, G., Zhao, J., Niu, Z., MacGowan, D., Capolicchio, T., Song, A., Gul, S., Moiz, A., Mahmud, A., Herrera, I., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-09239-6 · Cited by 3
The Prevention and Treatment of Adolescent Stimulant and Methamphetamine Use
Strickland, J. C., & Stoops, W. W. (2018) · Issues in children's and families' lives · doi:10.1007/978-3-319-90611-9_9 · Cited by 2
Poulin, M.-H., Laventure, M., Tremblay, K., & Beuchot, E. (2021) · Drogues santé et société · doi:10.7202/1075337ar · Cited by 4
Use of methylphenidate by university students in the health area
de Freitas, A. C. Z. P., Moreira, S. M., Lago, L. M., Pinheiro, L. N., da Silva, D. S. P., Araújo, M. C., de Oliveira, L. C., Costa, J. B., Chaves, V. T. A., & Chaves, A. C. T. A. (2021) · Research Society and Development · doi:10.33448/rsd-v10i8.17540 · Cited by 7
Psychopharmacology of Pediatric Attention-Deficit/Hyperactivity Disorder
Greydanus, D. E., Rowland, D. C., Patel, D. R., & Soares, N. S. (2021) · Psychiatric Annals · doi:10.3928/00485713-20210914-01 · Cited by 3
Bruyn, S. D., Ponnet, K. S., Tholen, R., Hal, G. F. V., & Wouters, E. (2022) · Substance Use & Misuse · doi:10.1080/10826084.2022.2034870 · Cited by 8
“The misuse of prescription stimulants among students has received increasing interest in both the academic and the public debate (Benson et al., 2015; Wilens et al., 2008).”
BackgroundResultInfluentialYates, J. R., Broderick, M. R., Berling, K. L., Gieske, M. G., Osborn, E., Nelson, M. R., & Wright, M. R. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.110970 · Cited by 3
Wang, H., Fei, Y., Zhang, Q., Deng, K., Liang, J., Sun, C., & Li, X. (2024) · IEEE International Conference on Robotics and Biomimetics (ROBIO) · doi:10.1109/robio64047.2024.10907569 · Cited by 2
Scalese, M., Baroni, M., Biagioni, S., Bastiani, L., Denoth, F., & Molinaro, S. (2025) · Journal of Public Health · doi:10.1007/s10389-025-02455-8 · Cited by 3
“…prevalence ranged from 1.7% to 3.0% (Young et al. 2012), while other research also documented that PSWMP are widely available on college campuses for non-medical use, owing in part to their pharmacological properties as stimulant drugs (Arria et al. 2008; Rabiner et al. 2009; Wilens et al. 2008).”
InfluentialAppling, C. B., Nuraini, N., Hart, E. S., Wang, D., Tosh, A. K., Beversdorf, D. Q., & Ferguson, B. J. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14103570 · Cited by 2
“These pharmacotherapies act as DA and NE agonists, inhibiting the reuptake of catecholamines to increase their availability in the synaptic cleft [5,6].”
Cognitive Development Considerations for Long-term Safety Exposures in Children
Pipan, M. E., Wang, P. P., & Penna, R. T. (2013) · Wiley eBooks · doi:10.1002/9781118312087.ch30 · Cited by 3
He, J. A., Sense, F., & Antshel, K. M. (2015) · The ADHD Report · doi:10.1521/adhd.2015.23.1.1 · Cited by 3
Cardiovascular Events in Adults Taking Medications for ADHD—Reply
FIREMAN, B. H. (2012) · JAMA · doi:10.1001/jama.2012.449 · Cited by 2
A re-think on drug policy in sport requires an enhanced conception of enhancement
Partridge, B. (2013) · Performance Enhancement & Health · doi:10.1016/j.peh.2013.08.012 · Cited by 2
Attention-deficit hyperactivity disorder and the substance use disorders in ADHD
Wilens, T. E., & Morrison, N. R. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139035491.011 · Cited by 4
Self-citationSafety of Psychotropic Drugs in Children and Adolescents
Kaguelidou, F., & Acquaviva, É. (2015) · Springer eBooks · doi:10.1007/978-3-319-24741-0_13 · Cited by 2
Binhadyan, B., & Wickramasinghe, N. S. (2015) · Advances in healthcare information systems and administration book series · doi:10.4018/978-1-4666-9446-0.ch005 · Cited by 2
Cannabis and Methylphenidate-Induced Manic Symptoms
Cinosi, M. C. E. (2015) · Journal of Clinical Toxicology · doi:10.4172/2161-0495.1000254 · Cited by 2
“The prevalence rates of psychostimulants use among university students may be particularly high, ranging broadly from 1 to 38% [6-12].”
BackgroundNon-stimulant treatment of ADHD
Pedraza, J. D., & Newcorn, J. H. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139035491.022 · Cited by 4
Thier, R., & Gresser, U. (2017) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2017.74015 · Cited by 4
Stimulant Overprescribing, Abuse, and Diversion
Ahmed, S., & Virani, S. (2017) · American Journal of Psychiatry Residents Journal · doi:10.1176/appi.ajp-rj.2017.120905 · Cited by 2
WEINBERG, N. Z., Lopez, M. F., & Compton, W. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00003-4 · Cited by 2
Markotić, F., Ćurković, M., Pekez-Pavliško, T., Vrdoljak, D., Vojvodić, Ž., Jurisic, D., Puljiz, M., Novinscak, M., Bonassin, K., Hajdarović, S. P., et al. (2021) · Healthcare · doi:10.3390/healthcare9050541 · Cited by 2
“Analgesics belong to a group of prescription medications that are most commonly shared among patients [6,7,9,11].”
BackgroundWeyandt, L. L., & DuPaul, G. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5345-1_6 · Cited by 2
Pharmakologisches Neuroenhancement
Maier, L. J. (2017) · Springer eBooks · doi:10.1007/978-3-642-55125-3_60 · Cited by 3
Fluoxetine misuse by snorting in a teenager: a case report
Khoodoruth, M. A. S. (2022) · International Journal of Psychiatric Trainees · doi:10.55922/001c.36361 · Cited by 2
Increasing the Age at Onset for ADHD?
FRANCES, A. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10010097 · Cited by 2
Adult ADHD:Diversion and Misuse of Medications
Spencer, T. J. (2008) · CNS Spectrums · doi:10.1017/s1092852900003266 · Cited by 2
Robinson, E. V. (2016) · University of North Texas Digital Library (University of North Texas) · doi:10.12794/metadc862790 · Cited by 3
Acute exercise and executive function in young adults with ADHD
Jones, G. J., Ehly, S. W., Liu, W. M., Westefeld, J. S., Wood, S. M., & Vispoel, W. P. (2015) · doi:10.17077/etd.fh103jlr · Cited by 2
“potentially addictive psychostimulant medications (Biederman, Monuteaux, Spencer, Wilens, MacPherson, & Faraone, 2008; Wilens et al., 2008).”
Non-medical use of prescription drugs
Bettinardi–Angres, K., Bickelhaupt, E. E., & Bologeorges, S. (2012) · The Nurse Practitioner · doi:10.1097/01.npr.0000415242.77611.15 · Cited by 1
“A recent review article found that 5% to 9% of grade school and high school students and 5% to 35% of college students use stimulants nonmedically.(19)”
BackgroundMcCombie, R. P., & Slanina, H. (2016) · Internet Journal of Allied Health Sciences and Practice · doi:10.46743/1540-580x/2016.1562 · Cited by 2
Tummala–Narra, P., Gonzalez, L. D., & Hailes, H. P. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108678971.029 · Cited by 1
The Cambridge Handbook of Community Psychology: Interdisciplinary and Contextual Perspectives
(2021) · Cambridge University Press eBooks · doi:10.1017/9781108678971 · Cited by 4
Therapeutic Use of Dopamine Enhancers (Stimulants)
Zuddas, A., & Carucci, S. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_138-1 · Cited by 1
Ramachandran, S., Dunn, T. J., Goswami, S., Zhang, Y., & Bentley, J. P. (2023) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2023.08.005 · Cited by 1
Managing ADHD in Adolescence and Young Adulthood: Emerging Comorbidities and Tailored Treatment
Canales, I. E. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-248-3_9 · Cited by 2
“There is evidence that treatment of ADHD signi fi cantly reduces risk for substance use in younger individuals with ADHD [ 29 ] although this effect may attenuate by adulthood.”
BackgroundAmphetamines, methylphenidate and excessive sleepiness
McCann, U. D. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511762697.037 · Cited by 1
Custode, K., & McManus, J. (2012) · InTech eBooks · doi:10.5772/39045 · Cited by 4
“More recent studies indicate higher rates with up to 35% of surveyed undergraduate students reporting the use of stimulant medications without a prescription (DeSantis, Webb, & Noar, 2008; Judson & Langdon, 2009; Wilens et al., 2008).”
BackgroundAssessment of adult attention-deficit/hyperactivity disorder
Bhat, V., & Paris, J. (2014) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.130170 · Cited by 3
Ritalin Use Modifies Alcohol Effects in Rats
Sonne, B. R., & Dafny, N. (2014) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2014.410044 · Cited by 1
“Methylphenidate (MPD) is the most commonly prescribed medication for the treatment of ADHD [1] [3] [8] [11] [25] [28] [29] and shares similar chemical structure and properties with cocaine and amphetamine [6] [7] [30][34], which are well known drugs of abuse.”
Future Directions for Practice and Research
Weyandt, L. L., & DuPaul, G. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5345-1_7 · Cited by 1
Singh, P., White, S. J., Saleem, K., & Luty, J. S. (2015) · Journal of Mental Health · doi:10.3109/09638237.2015.1057331 · Cited by 2
“early age and have higher rates of substance dependence (Goodman, 2007; Wilens et al., 2008).”
BackgroundLuty, J. S. (2016) · BJPsych Advances · doi:10.1192/s2056467800002851
“Wilens et al (2008) hanno effettuato una revisione di 21 studi (riguardanti oltre 100000 bambini e adolescenti) stimando l’abuso dei farmaci stimolanti prescritti per il Disturbo da deficit di attenzione/iperattività (principalmente il metilfenidato): i tassi di uso “deviato” di farmaci stimolanti…”
ADHD and Substance Abuse in Children and Adolescents
Sadek, J. R. (2018) · Springer eBooks · doi:10.1007/978-3-319-45635-5_7 · Cited by 1
Psychopharmaka zum pharmakologischen Neuroenhancement und ihr Missbrauchspotenzial
Franke, A. G. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23021-9.00025-4 · Cited by 2
Metadata
- Authors
- WILENS, T. E., ADLER, L. A., ADAMS, J., SGAMBATI, S., ROTROSEN, J., SAWTELLE, R., UTZINGER, L., & FUSILLO, S.
- Affiliations
- Harvard University (US)
- Corresponding author
- WILENS, TIMOTHY E.
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 47
- Issue
- 1
- Pages
- 21-31
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W1970031540
- Cited by
- 824
- References
- 56
- Citations by year
- 2026: 16 · 2025: 44 · 2024: 21 · 2023: 17 · 2022: 26 · 2021: 87 · 2020: 43 · 2019: 50 · 2018: 36 · 2017: 49 · 2016: 60 · 2015: 52 · 2014: 73 · 2013: 49 · 2012: 70
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- the National Institute of Drug Abuse (U10 DA15831 and U10 DA13046)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Arts and Humanities › Philosophy › Neuroethics, Human Enhancement, Biomedical Innovations
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- stimulant abuse, prescription drug diversion, ADHD medication, adolescents, young adults, university students, risk factors
- MeSH terms
- Adolescent, Adult, Amphetamines, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Cross-Sectional Studies, Female, Health Surveys, Humans, Male, Methylphenidate, Drug Prescriptions, Self Administration, Illicit Drugs, United States, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.